Showing results (41-50 of 240) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|September 6, 2017
What does endotyping mean for treatment in chronic obstructive pulmonary disease?Alvar Agustí, Bartolome Celli, Rosa Faner
Medicina Clinica|March 13, 2022
Beyond the COPD-tobacco binomium: New opportunities for the prevention and early treatment of the diseaseMarc Vila, Rosa Faner, Alvar Agustí
Thorax|April 21, 2026
Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY studySusan Muiser, Hana Müllerová, Laura Belton, et al.
BMJ Open|July 20, 2026
Respiratory syncytial virus infection in COPD exacerbations: the RECODE study protocolAlvar Agusti, Rosario Menéndez, Elisa Salamanca, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 11, 2020
Treatable Traits That Predict Health Status and Treatment Response in Airway DiseaseSarah A Hiles, Peter G Gibson, Alvar Agusti, et al.
Respirology (Carlton, Vic.)|June 11, 2024
Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established diseaseShyamali C Dharmage, Rosa Faner, Alvar Agustí
The European Respiratory Journal|February 14, 2018
Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotypeBartolome R Celli, Nicholas Locantore, Ruth Tal-Singer, et al.
Lancet (London, England)|May 7, 2015
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised managementPrescott G Woodruff, Alvar Agusti, Nicolas Roche, et al.
ERJ Open Research|September 16, 2021
Lung function trajectory and biomarkers in the Tasmanian Longitudinal Health StudyDinh S Bui, Alvar Agusti, Haydn Walters, et al.
The Lancet. Respiratory Medicine|November 19, 2017
Lung function in early adulthood and health in later life: a transgenerational cohort analysisAlvar Agustí, Guillaume Noell, Josep Brugada, et al.
Pageof 24